Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 25/10/2016 |
| Corporate Officer/Principal | 64 | 01/01/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 25/10/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.52% | -7.19% | +51.66% | +69.99% | 65.83B | |
| +0.41% | +8.72% | +11.36% | +84.98% | 51.87B | |
| +2.47% | +3.98% | +2.36% | +64.84% | 51.2B | |
| -0.38% | +1.40% | +29.98% | +42.37% | 43.76B | |
| +0.30% | +5.64% | +16.99% | +133.30% | 42.09B | |
| +2.35% | -6.08% | +236.69% | +528.10% | 39.04B | |
| +2.16% | +9.87% | +18.92% | +59.70% | 34B | |
| +3.84% | -2.34% | +39.18% | +8.57% | 25.2B | |
| +0.26% | +3.04% | +28.11% | +23.30% | 22.8B | |
| Average | +1.41% | +0.27% | +48.36% | +112.80% | 41.76B | |
| Weighted average by Cap. | +1.33% | +0.20% | +46.97% | +114.94% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
